1KX
{(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl}methanol
| Created: | 2011-12-06 |
| Last modified: | 2021-03-01 |
Find Related PDB Entry |
|---|
Find related ligands:Help |
|---|
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 39 |
| Chiral Atom Count | 2 |
| Bond Count | 42 |
| Aromatic Bond Count | 10 |
Chemical Component Summary | |
|---|---|
| Name | {(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl}methanol |
| Synonyms | Abacavir |
| Systematic Name (OpenEye OEToolkits) | [(1S,4R)-4-[2-azanyl-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol |
| Formula | C14 H18 N6 O |
| Molecular Weight | 286.332 |
| Type | NON-POLYMER |
Chemical Descriptors | |||
|---|---|---|---|
| Type | Program | Version | Descriptor |
| SMILES | ACDLabs | 12.01 | n1c(c2ncn(c2nc1N)C3C=CC(CO)C3)NC4CC4 |
| SMILES | CACTVS | 3.370 | Nc1nc(NC2CC2)c3ncn([CH]4C[CH](CO)C=C4)c3n1 |
| SMILES | OpenEye OEToolkits | 1.7.6 | c1nc2c(nc(nc2n1C3CC(C=C3)CO)N)NC4CC4 |
| Canonical SMILES | CACTVS | 3.370 | Nc1nc(NC2CC2)c3ncn([C@@H]4C[C@H](CO)C=C4)c3n1 |
| Canonical SMILES | OpenEye OEToolkits | 1.7.6 | c1nc2c(nc(nc2n1[C@@H]3C[C@@H](C=C3)CO)N)NC4CC4 |
| InChI | InChI | 1.03 | InChI=1S/C14H18N6O/c15-14-18-12(17-9-2-3-9)11-13(19-14)20(7-16-11)10-4-1-8(5-10)6-21/h1,4,7-10,21H,2-3,5-6H2,(H3,15,17,18,19)/t8-,10+/m1/s1 |
| InChIKey | InChI | 1.03 | MCGSCOLBFJQGHM-SCZZXKLOSA-N |
Drug Info: DrugBank
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| DrugBank ID | DB01048 |
|---|---|
| Name | Abacavir |
| Description | Abacavir (ABC) is a powerful nucleoside analog reverse transcriptase inhibitor (NRTI) used to treat HIV and AIDS. Chemically, it is a synthetic carbocyclic nucleoside and is the enantiomer with 1S, 4R absolute configuration on the cyclopentene ring. In vivo, abacavir sulfate dissociates to its free base, abacavir. |
| Synonyms |
|
| Indication | Abacavir is indicated in combination with other anti-retroviral agents for the treatment of HIV-1 infection.[L30400] It is available in a combination product alongside [dolutegravir] and [lamivudine] for the treatment of adult and pediatric patients with HIV-1 who weigh ≥10 kg.[L41365] |
| Categories |
|
| ATC-Code |
|
| CAS number | 136470-78-5 |
Drug Targets
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| Name | Target Sequence | Pharmacological Action | Actions |
|---|---|---|---|
| Reverse transcriptase/RNaseH | PISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKI... | unknown | inhibitor |
| HLA class I histocompatibility antigen, B-57 alpha chain | MRVTAPRTLLLLLWGAVALTETWAGSHSMRYFHTSVSRPGRGEPRFITVG... | unknown | |
| Adenosine kinase | MAAAEEEPKPKKLKVEAPQALRENILFGMGNPLLDISAVVDKDFLDKYSL... | unknown | substrate |
| Alcohol dehydrogenase 6 | MCTTGQVIRCKAAILWKPGAPFSIEEVEVAPPKAKEVRIKVVATGLCGTE... | unknown | substrate |
| UDP-glucuronosyltransferase 1-1 | MAVESQGGRPLVLGLLLCVLGPVVSHAGKILLIPVDGSHWLSMLGAIQQL... | unknown | substrate |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
| Resource Name | Reference |
|---|---|
| PubChem | 441300 |
| ChEMBL | CHEMBL1380 |
| ChEBI | CHEBI:421707 |
| CCDC/CSD | CUHGAO, TATNOV, TATNUB |
| COD | 2222848 |














